EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMixed-Methods-StudieOpen Access · CC BY 4.0

Acceptability and feasibility of long-term, real-time electronic adherence monitoring of HIV pre-exposure prophylaxis (PrEP) use among young women in Kenya: A mixed methods study

Vallery A Ogello, Bernard Kipkoech Rono iD, Kenneth Ngure, Eric Sedah iD, Nicholas B Thuo, Nicholas Musinguzi, Jared M Baeten, Elizabeth A Bukusi iD, Nelly R Mugo, Jessica E Haberer iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0299168 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Vallery A Ogello und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, Anti-HIV Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Real-time electronic adherence monitoring involves “smart” pill boxes that record and monitor openings as a proxy for pill taking and may be useful in understanding and supporting PrEP use; however, acceptability and/or feasibility for PrEP users is uncertain. We sought to understand the experiences of using a real-time electronic adherence monitor for PrEP delivery among young women in Kisumu and Thika, Kenya. We used the Wisepill device to monitor PrEP use among 18-24-year-old women for two years. Half of the participants were randomized to also receive SMS adherence reminders (daily or as needed for missed doses). We assessed acceptability quantitatively and qualitatively according to the four constructs of Unified Theory of Acceptance and Use of Technology (UTAUT): performance expectancy, effort expectancy, social influence, and facilitating conditions. We assessed feasibility by monitor functionality during periods of PrEP use. We analyzed quantitative data descriptively and compared by site and over time; qualitative data were analyzed inductively and deductively. The median age was 21 years (IQR 19–22), median education was 12 years (IQR 10–13), 182 (53%) had disclosed PrEP use, and 55 (16%) reported recent intimate partner violence. Most participants reported high levels of usefulness and high interest in using the monitor with few problems or worries reported throughout follow-up. Feasibility was high overall with some differences by site (96% functional monitor days in Kisumu vs 88% in Thika). Few monitors were reported lost (N = 29; 8%) or dysfunctional (N = 11; 3%). In qualitative interviews, electronic monitoring was perceived as useful because it supported privacy, confidentiality, easy storage, and PrEP adherence. Effort was generally considered low. Participants expressed some concern for stigma from monitor and/or PrEP use. Facilitating conditions involved the monitor size, color, and battery life. Overall, real-time electronic adherence monitoring was a highly acceptable and feasible approach to understand PrEP adherence among young women in a sub-Saharan African setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPre-Exposure ProphylaxisAnti-HIV AgentsHumansFemaleYoung AdultAdultAdolescentKenyaFeasibility StudiesMedication AdherenceElectronics

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Center of Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Center for microbiology research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
  • Department of Global Health, University of Washington, Seattle, Washington, United States of America.
  • Global Health Collaborative, Mbarara, Uganda.
  • Gilead Sciences, Foster City, California, United States of America.

ORCID-Profile: Bernard Kipkoech Rono, Eric Sedah, Elizabeth A Bukusi, Jessica E Haberer

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Ogello, V. A., Rono, B. K., Ngure, K., Sedah, E., Thuo, N. B., Musinguzi, N., Baeten, J. M., Bukusi, E. A., Mugo, N. R., & Haberer, J. E. (2024). Acceptability and feasibility of long-term, real-time electronic adherence monitoring of HIV pre-exposure prophylaxis (PrEP) use among young women in Kenya: A mixed methods study. PLOS ONE. https://doi.org/10.1371/journal.pone.0299168

Vancouver

Ogello VA, Rono BK, Ngure K, Sedah E, Thuo NB, Musinguzi N, et al. Acceptability and feasibility of long-term, real-time electronic adherence monitoring of HIV pre-exposure prophylaxis (PrEP) use among young women in Kenya: A mixed methods study. PLOS ONE. 2024. doi:10.1371/journal.pone.0299168

BibTeX
@article{Ogello2024,
  author = {Ogello, Vallery A and Rono, Bernard Kipkoech and Ngure, Kenneth and Sedah, Eric and Thuo, Nicholas B and Musinguzi, Nicholas and Baeten, Jared M and Bukusi, Elizabeth A and Mugo, Nelly R and Haberer, Jessica E},
  title = {Acceptability and feasibility of long-term, real-time electronic adherence monitoring of HIV pre-exposure prophylaxis (PrEP) use among young women in Kenya: A mixed methods study},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0299168}
}
Kostenlos starten →